Spetzler David Baxleyinsider trades
In SEC Form 4 filings, Spetzler David Baxley is listed as President of Caris Life Sciences, Inc. (CAI). In the last 90 days, Spetzler David Baxley sold $14.83M of Caris Life Sciences, Inc. (CAI) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| CAICaris Life Sciences, Inc. | President | 7 | Sep 4 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-04
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CAICaris Life Sciences, Inc. | Sep 4 | Sep 4 | M | 250,000 | $2.44 | $610,000 | 1,302,083 | No | Form 4 |
| CAICaris Life Sciences, Inc. | Sep 4 | Sep 4 | S | 119,212 | $24.76 | Sale −$2,951,117 | 1,182,871 | No | Form 4 |
| CAICaris Life Sciences, Inc. | Sep 4 | Sep 4 | M · derivative | 250,000 | $2.44 | $610,000 | not reported | No | Form 4 |
| CAICaris Life Sciences, Inc. | Sep 3 | Sep 4 | M | 1,000,000 | $2.44 | $2,440,000 | 1,530,083 | No | Form 4 |
| CAICaris Life Sciences, Inc. | Sep 3 | Sep 4 | S | 393,100 | $24.76 | Sale −$9,733,313 | 1,136,983 | No | Form 4 |
| CAICaris Life Sciences, Inc. | Sep 3 | Sep 4 | S | 84,900 | $25.32 | Sale −$2,149,676 | 1,052,083 | No | Form 4 |
| CAICaris Life Sciences, Inc. | Sep 3 | Sep 4 | M · derivative | 1,000,000 | $2.44 | $2,440,000 | 250,000 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.